Abstract
The activation of toxic chemicals and carcinogens into reactive intermediates involves oxygenation in hindered positions of the molecule, by cytochrome P-448 (LM4), flavoprotein oxidoreductases, or transoxygenation during prostaglandin biosynthesis. Cytochrome P-450 (LM2) does not oxygenate in hindered positions and therefore generally detoxicates carcinogens and toxic chemicals. Cytochrome P-448 has a different active site from cytochrome P-450, which enables it to oxygenate substrates in conformationally-hindered positions.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Andersson B, Nordenskjöld M, Rahimtula A, Moldeus P (1982) Prostaglandin synthetase-catalysed activation of phenacetin metabolites to genotoxic products. Mol Pharmacol 22: 479–485
Bidelman K, Mannering GJ (1970) Induction of drug metabolism. V. Independent formation of cytochrome P-450 and P1450 in rats treated with phenobarbital and 3-methylcholanthrene simulatenously. Mol Pharmacol 6: 697–701
Burke MD, Mayer RT (1975) Inherent specificities of purified cytochromes P-450 and P-448 towards biphenyl hydroxylation and ethoxyresorufin deethylation. Drug Metab Dispos 3: 245–253
Cohen G, Cederbaum AI (1979) Chemical evidence of production of hydroxyl radicals during microsomal electron transport. Science 204: 66–68
Delaforge M, Ioannides C, Parke DV (1982) Selective inhibition of the safrole-induced mixed-function oxidase activities by 9-hydroxyellipticine. Chem Biol Interactions 42:279–289
Dus KM (1982) Insights into the active site of the cytochrome P-450 haemoprotein family — a unifying concept based on a structural considerations. Xenobiotica 12: 745–772
Frederick CB, Mays JB, Ziegler DM, Guengerich FP, Kadlubar FF (1982) Cytochrome P-450 and flavin-containing monooxygenase-catalysed formation of the carcinogen N-hydroxy-2-amino-fluorene and its covalent binding to nuclear DNA. Cancer Res 42: 2671–2677
Hara E, Kawajiri K, Gotoh O, Tagashira Y (1981) Immunochemical study on the contributions of two molecular species of microsomal cytochrome P-450 to the metabolism of 2-acetylamino-fluorene by rat liver microsomes. Cancer Res 41: 253–257
Hashimoto C, Imai Y (1976) Purification of a substrate complex of cytochrome P-450 from liver microsomes of 3-methylcholanthrene-treated rabbits. Biochem Biophys Res Commun 68:821–827
Igarashi S, Yonekawa H, Kawajiri K, Watanabe J, Kimura T, Kodama M, Nagata C, Tagashira Y (1982) Participation of the microsomal electron transport system in mutagenic activation of 4-dimethylaminoazobenzene, 4-methylaminoazobenzene, and their 3′-methyl derivatives. Biochem Biophys Res Commun 106: 164–169
Ingelman-Sunberg M, Habjörk AL (1982) On the significance of the cytochrome P-450-dependent hydroxyl radical-mediated oxygenation mechanism. Xenobiotica 11: 673–686
Ioannides C, Parke DV (1975) Mechanism of induction of hepatic microsomal drug metabolizing enzymes by a series of barbiturates. J Pharm Pharmacol 27: 739–746
Ioannides C, Parkinson C, Parke DV (1981a) Activation of benzo(a)pyrene and 2-acetamidoflu- orene to mutagens by microsomal preparations from different animal species: Role of cytochrome P-450 and P-448. Xenobiotica 11: 701–708
Ioannides C, Delaforge M, Parke DV (1981b) Safrole: Its metabolism, carcinogenicity and interactions with cytochrome P-450. Food Cosmet Toxicol 19: 657–666
Ioannides C, Steele CM, Parke DV (1983) Species variation in the metabolic activation of paracetamol to toxic intermediates: Role of cytochromes P-450 and P-448. Toxicol Lett 16:55–61
Jefcoate CR, Gaylor J (1969) Ligand interactions with hemoprotein P-450. II Influence of phenobarbital and methylcholanthrene induction processes on P-450 spectra. Biochemistry 8: 3464–3472
Johnson EF, Levitt DS, Muller-Eberhard U, Thorgeirsson SS (1980) Catalysis of divergent pathways of 2-acetylaminofluorene metabolism by multiple forms of cytochrome P-450. Cancer Res 40: 4456–4459
Lai C-S, Grover TA, Piette LH (1979) Hydroxyl radical production in a purified NADPH-cy- tochrome c (P-450) reductase system. Arch Biochem Biophys 193: 373–378
Levin W, Wood AW, Lu AYH, Ryan D, West S, Conney AH, Thakker DR, Yagi H, Jerina DM (1977) Role of purified cytochrome P-448 and epoxide hydrase in the activation and detoxication of benzo(a)pyrene. In: Jerina DM (ed) ACS symposium, Drug metabolism concepts. American Chemical Society, Washinton, DC, pp 99–125
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagents. J Biol Chem 193: 265–275
Lu AYH, West SB (1980) Multiplicity of mammalian microsomal cytochromes P-450. Pharmacol Rev 31: 277–295
Lu AYH, Kuntzman R, West S, Jacobson M, Conney AH (1972) Reconstituted liver microsomal enzyme that hydroxylates drugs, other foreign compounds and endogenous substrates. II Roles of the cytochrome P-450 and P-448 fractions in drug and steroid hydroxylations. J Biol Chem 247:1727–1734
Nebert DW, Negishi M (1982) Multiple forms of cytochrome P-450 and the importance of molecular biology and evolution. Biochem Pharmacol 31: 2311–2317
Nebert DW, Goujon GM, Gielen JE (1972) Aryl hydrocarbon hydroxylase induction by polycyclic hydrocarbons: simple autosomal dominant trait in the mouse. Nature (New Biol) 236:107–110
Nebert DW, Bigelow SW, Okey AB, Yahagi T, Mori Y, Nagao M, Sugimura T (1979) Pyrolysis products from amino acids and protein: Highest mutagenicity requires cytochrome P1450. Proc Natl Acad Sci USA 76: 5929–5933
Nelson SD (1982) Metabolic activation and drug toxicity. J Med Chem 25: 753–765
Omura T, Sato R (1964) The carbon monoxide pigment of liver microsomes. I. Evidence for its haemoprotein nature. J Biol Chem 239: 2370–2378
Parke DV (1983) Mechanism of chemical toxicity — A unifying hypothesis. Regul Toxicol Pharmacol 2:267–286
Parke DV, Ioannides C (1982) Role of mixed-function oxidases in the formation of biological reactive intermediates. Adv Exp Med Biol 136A: 23–38
Phillipson CE, Ioannides C, Delaforge M, Parke DV (1982) Studies on the substrate-binding sites of liver microsomal cytochrome P-448. Biochem J 207: 51–56
Poland AP, Glover E, Kende AS (1976) Stereospecific, high-affinity binding of 2,3,7,8-tetra- chlorodibenzo-p-dioxin by hepatic cytosol. Evidence that the binding species is the receptor for the induction of aryl hydrocarbon hydroxylase. J Biol Chem 251: 4936–4946
Reiter R, Wendel A (1982) Chemically-induced glutathione depletion and lipid peroxidation. Chem Biol Interact 40:365–374
Schenkmann JB (1970) Studies on the nature of the type I and type II spectral changes in liver microsomes. Biochemistry 9:2081–2091
Statham CN, Boyd MR (1982) Effects of phenobarbital and 3-methylcholanthrene on the in vivo distribution, metabolism and covalent binding of 4-ipomeanol in the rat; implications for target organ toxicity. Biochem Pharmacol 31: 3973–3977
Steele CM, Masson HA, Battershill JM, Gibson GG, Ioannides C (1983) Metabolic activation of paracetamol by highly purified forms of cytochrome P-450. Res Commun Chem Pathol Pharmacol 40:109–119
Thorgeirsson SS, Felton JS, Nebert DW (1975) Genetic differences in the aromatic hydrocarbon-inducible N-hydroxylation of 2-acetylaminofiuorene and acetaminophen-produced hepa-totoxicity in mice. Mol Pharmacol 11: 159–165
Trush MA, Mimnaugh EG, Gram TE (1982) Activation of pharmacologic agents to radical intermediates. Implications for the role of free radicals in drug action and toxicity. Biochem Pharmacol 31: 3335–3346
Tukey RH, Hannah RR, Negishi M, Nebert DW, Howard JE (1982) The Ah locus: Correlation of intranuclear appearance of inducer-receptor complex with induction of cytochrome Pr450 mRNA. Cell 31: 275–2854
Yang CS, Strickhart FS, Kicha LP (1978) Analysis of the aryl hydrocarbon hydroxylase assay. Biochem Pharmacol 27: 2321–2326
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Springer-Verlag
About this paper
Cite this paper
Parke, D.V., Ioannides, C. (1984). Active Metabolites in Toxicology: The Role of Cytochrome P-448 and Flavoprotein Oxidases. In: Chambers, P.L., Preziosi, P., Chambers, C.M. (eds) Disease, Metabolism and Reproduction in the Toxic Response to Drugs and Other Chemicals. Archives of Toxicology, vol 7. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-69132-4_27
Download citation
DOI: https://doi.org/10.1007/978-3-642-69132-4_27
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-12452-8
Online ISBN: 978-3-642-69132-4
eBook Packages: Springer Book Archive